Chinese American biologist Feng Zhang (張鋒), one of the three recipients of the Tang Prize in biopharmaceutical science, said the prize was recognition for his entire lab for its research on the CRISPR/Cas9 genome editing tool.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
3 firms enforce furloughs due to U.S. tariff impact
05/01/2025 03:52 PM - Politics
Cabinet approves draft amendment to extend tax rebates for appliances
05/01/2025 03:37 PM - Politics
Taiwan to send team to Geneva despite no invitation to WHA event
05/01/2025 03:30 PM - Society
Fugitive Taiwanese blogger repatriated on suspicion of fraud
05/01/2025 02:42 PM - Politics
Gov't to continue enhancing workers' protections: Lai
05/01/2025 02:14 PM